CellSeed Inc. (TSE: 7776)
Health Care · Biotechnology · JP
¥206.00
-2.37% today · -52.8% 1Y
CellSeed Inc. (TSE: 7776) operates in the Biotechnology industry within the Health Care sector. The company is valued at $51.50M and employs 36 people.
Over the last twelve months the share price has lost 52.8%, trading between 200.00 and 462.00.
Tweenvest scores CellSeed Inc. across four factors: quality 36/100, value 48/100, growth 0/100. Its strongest factor is value.
7776 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $51.50M
- Revenue (TTM)
- $1.40M
- P/E
- —
- EPS
- -53.15
- Dividend yield
- —
- Beta (5Y)
- 1.21
- 52-week high
- ¥462.00
- 52-week low
- ¥200.00
- Avg volume (3M)
- —
- Shares outstanding
- 39.47M
- Employees
- 36
- Next earnings
- —
About CellSeed Inc.
CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell sheet technology. The company is deeply involved in the research, development, and market introduction of advanced cell-sheet medicine products. Its innovations encompass epithelial cell sheets for repairing the esophagus, as well as both regenerated cartilage sheets and chondrocyte sheets aimed at addressing knee osteoarthritis. Beyond its therapeutic pipeline, CellSeed manufactures and distributes a range of specialized cell cultureware. This includes UpCell, a temperature-responsive cultureware vital for cell-sheet engineering; RepCell, another temperature-sensitive product designed for efficient cell collection; and HydroCell, distinguished by its low cell-binding properties. The firm also provides supporting equipment, such as ThermoPlate III, a heating element constructed from transparent glass, and cellZscope, an automated system for real-time cell monitoring. Additionally, CellSeed offers contract development and manufacturing services. Founded in 2001, the company's main operations are situated in Tokyo, Japan.
- ISIN
- JP3423530009
- Founded
- 2001
- Listed since
- Mar 16, 2010
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Helix BioPharma Corp.TSX: HBP | $52.92M | CA$0.98 | +6.52% |
| Sirnaomics Ltd.SEHK: 2257 | $52.66M | HK$3.80 | +1.34% |
| UBI Pharma Inc.UNQ: 6562 | $52.10M | NT$— | — |
| CG Invites Co., Ltd.KOSDAQ: A083790 | $52.02M | ₩902.00 | -3.01% |
| RenovoRx, Inc.NasdaqCM: RNXT | $51.45M | $1.14 | -10.94% |
| Synbio Tech Inc.TPEX: 1295 | $51.37M | NT$48.35 | -3.49% |
| Prestige BioPharma LimitedKOSE: A950210 | $51.30M | ₩5,690.00 | -4.53% |
| Nano Holdings, Inc.TSE: 4571 | $51.13M | ¥89.00 | +12.66% |
Figures last refreshed Oct 18, 2026.